|
CD9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.12419999999769E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.776400E-04 |
| Normal-vs-Stage2 |
2.01899999999755E-05 |
| Normal-vs-Stage3 |
4.93079999996926E-06 |
| Normal-vs-Stage4 |
6.841200E-03 |
| Stage1-vs-Stage2 |
6.418000E-02 |
| Stage1-vs-Stage3 |
2.199600E-02 |
| Stage1-vs-Stage4 |
4.142600E-01 |
| Stage2-vs-Stage3 |
7.339200E-01 |
| Stage2-vs-Stage4 |
9.670000E-01 |
| Stage3-vs-Stage4 |
8.375800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50284000000056E-05 |
| Normal-vs-AfricanAmerican |
2.784000E-03 |
| Normal-vs-Asian |
5.151900E-02 |
| Caucasian-vs-AfricanAmerican |
8.488100E-02 |
| Caucasian-vs-Asian |
9.572600E-01 |
| AfricanAmerican-vs-Asian |
4.714800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88230000000011E-05 |
| Normal-vs-Female |
9.646700E-04 |
| Male-vs-Female |
5.305800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.382600E-04 |
| Normal-vs-Extreme_Weight |
4.141400E-03 |
| Normal-vs-Obese |
2.005800E-04 |
| Normal-vs-Extreme_Obese |
1.503150E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.632400E-01 |
| Normal_Weight-vs-Obese |
9.059000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.265800E-01 |
| Extreme_Weight-vs-Obese |
7.115800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.261640E-01 |
| Obese-vs-Extreme_Obese |
1.751430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.385600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.355200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.576000E-04 |
| Normal-vs-Age(81-100Yrs) |
8.08320000000862E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.531000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.271200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.762400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.244800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.536300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.614620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.034400E-04 |
| Normal-VS-Type2 PRCC |
4.01889999945837E-07 |
| Normal-VS-KIRP CIMP |
3.69749999951097E-07 |
| Normal-VS-Unclassified PRCC |
7.630900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.74860000315513E-08 |
| Type1 PRCC-VS-KIRP CIMP |
4.179200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
8.911400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.396000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.883520E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.581700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.15260000002715E-06 |
| Normal-vs-N1 |
1.87607999999617E-05 |
| Normal-vs-N2 |
4.635800E-04 |
| N0-vs-N1 |
9.232400E-01 |
| N0-vs-N2 |
7.127400E-01 |
| N1-vs-N2 |
7.742800E-01 |
|
|
